The U.S. Food & Drug Administration (FDA) Approves Updated LUPKYNIS® (voclosporin) Label to include Long-Term Data from the AURORA Clinical Program

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. IBM
2. PRIM
3. META
4. NAVN
5. CNC
6. KFY
7. ABBV
8. MU
9. DPZ
10. PLTR

Go back to The U.S. Food & Drug Administration (FDA) Approves Updated LUPKYNIS® (voclosporin) Label to include Long-Term Data from the AURORA Clinical Program
(NASDAQ: AUPH) Delayed: 17.53 --0 (-0%)
Previous Close $17.53    52 Week High $5.69 
Open $17.53    52 Week Low $1.42 
Day High $17.53    P/E N/A 
Day Low $17.53    EPS $0.00 
Volume 4,412